Medicxi raises €200M to take 6 biotechs deeper into the clinic

Medicxi has secured €200 million ($235 million) to support six companies. The unidentified biotechs are drawn from the portfolio of a €150 million life science-focused fund that Index Ventures set up before spinning off Medicxi.